http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4180437-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_884170daee0baff8400371fa096c4d27 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8128 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-963 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-803 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate | 1977-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1979-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3eb583abb3dca737901da03a586add5 |
| publicationDate | 1979-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4180437-A |
| titleOfInvention | Purification of antiserum for thrombosis test |
| abstract | Antiserum which has been generated against an enzyme-inhibitor-complex is purified by immunoprecipitating a freshly generated antiserum with fresh human bloodplasma to form a precipitate and a fluid, and subjecting the fluid to chromatographic separation over an insolubilized enzyme-inhibitor complex against which the antiserum has been generated. A reagent for immunochemical assay is prepared by contacting the purified antiserum with red bloodcells or synthetic resin particles to obtain on the surface of the red bloodcells or synthetic resin particles antibodies from the antiserum. In a diagnosis test, blood plasma is contacted with the purified antiserum and with red bloodcells or synthetic resin particles which bear the enzyme-inhibitor complex used to prepare the antiserum, and whether or not agglutination occurs is ascertained. In an alternative diagnosis test, blood plasma is contacted with red bloodcells or synthetic resin particles having on their surface antibodies from the antiserum, and whether or not agglutination occurs is ascertained. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0741868-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0048989-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0048989-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4753875-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5308755-A |
| priorityDate | 1976-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.